PRESS RELEASE published on 05/16/2024 at 22:30, 2 years 4 months ago DBV Technologies Announces Results of its 2024 Combined General Meeting DBV Technologies announces successful results of its 2024 Combined General Meeting where shareholders approved all proposed resolutions. The Company focuses on treatment options for food allergies Resolutions Combined General Meeting DBV Technologies Food Allergies Treatment Options
BRIEF published on 05/09/2024 at 22:35, 2 years 4 months ago DBV Technologies announces its participation in two investor conferences in May DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
PRESS RELEASE published on 05/09/2024 at 22:30, 2 years 4 months ago DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies to participate in two upcoming investor conferences in May, presenting its clinical-stage biopharmaceutical developments. Learn more about their innovative treatment options Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
BRIEF published on 05/07/2024 at 22:35, 2 years 4 months ago DBV Technologies publishes its financial results for the first quarter of 2024 and provides an update on its activities DBV Technologies Financial Results Effectiveness Viaskin Peanut Regulatory Affairs Appointment Cash Flow Evolution VITESSE Clinical Trial
PRESS RELEASE published on 05/07/2024 at 22:30, 2 years 4 months ago DBV Technologies Reports First Quarter 2024 Financial Results and Business Update DBV Technologies reports Q1 2024 financial results and business update, with VITESSE enrollment progress, appointment of Chief Regulatory Officer, and $101.5 million cash balance Financial Results Q1 2024 DBV Technologies VITESSE Enrollment Chief Regulatory Officer
Published on 09/17/2026 at 15:55, 6 hours 6 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 6 hours 36 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 7 hours 1 minute ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 7 hours 1 minute ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 7 hours 11 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 3 hours 1 minute ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 3 hours 3 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 3 hours 36 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 3 hours 51 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 4 hours 15 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 4 hours 21 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 4 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 15 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
